Decadron W/ Xylocaine

   
Google
 
Web NewDrugInformation.com

Decadron W/ Xylocaine


Drug - Decadron W/ Xylocaine
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 4MG PHOSPHATE/ML;10MG/ML
The potency of the active ingredient(s), Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Decadron W/ Xylocaine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 013334
The FDA assigned number to Decadron W/ Xylocaine. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Decadron W/ Xylocaine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Decadron W/ Xylocaine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Decadron W/ Xylocaine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Decadron W/ Xylocaine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck And Co Inc
The full name of the firm holding legal responsibility for the new application of Decadron W/ Xylocaine.

Decadron W/ Xylocaine